Related Experiment Video
Updated: Jul 13, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Evaluation of dexamethasone pulse therapy in systemic sclerosis
1Dept. of Dermatology, STD Leprosy, Govt. Medical College and Associated SMSH Hospital, Srinagar, Kashmir (J & K).
Dexamethasone pulse therapy shows encouraging results for treating systemic sclerosis, a complex multisystem disorder. This treatment approach was well-tolerated with minimal adverse effects in patients who completed the regimen.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Systemic sclerosis is a multisystem autoimmune disorder with currently unsatisfactory treatment options.
- Developing effective therapeutic strategies for systemic sclerosis remains a significant clinical challenge.
Purpose of the Study:
- To evaluate the efficacy and tolerability of dexamethasone pulse therapy in patients with systemic sclerosis.
- To assess the potential of corticosteroid pulse therapy as a treatment for this debilitating condition.
Main Methods:
- A cohort of 25 patients diagnosed with systemic sclerosis received dexamethasone pulse therapy.
- Treatment outcomes and adverse events were monitored for patients completing the therapy regimen.
Main Results:
- Ten patients successfully completed the dexamethasone pulse therapy protocol.
- The results observed in these patients were encouraging, suggesting a positive therapeutic response.
- Adverse effects associated with the dexamethasone pulse therapy were minimal.
Conclusions:
- Dexamethasone pulse therapy presents a promising treatment option for systemic sclerosis.
- The observed encouraging outcomes and minimal side effects warrant further investigation into this therapeutic approach.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids